![Marc S. Ayers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marc S. Ayers
Chief Executive Officer at Romark, L.C.
Marc S. Ayers active positions
Companies | Position | Start | End |
---|---|---|---|
Romark, L.C.
![]() Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Chief Executive Officer | 1993-12-31 | - |
Founder | 1993-12-31 | - | |
President | 1993-12-31 | - | |
Romark Global Pharma LLC
![]() Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Director/Board Member | - | - |
Romark SCS
![]() Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg. | Director/Board Member | - | - |
Career history of Marc S. Ayers
Training of Marc S. Ayers
The University of Alabama | Graduate Degree |
Statistics
International
United States | 3 |
Luxembourg | 2 |
Operational
Director/Board Member | 2 |
Graduate Degree | 1 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Romark, L.C.
![]() Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Health Technology |
Romark Global Pharma LLC
![]() Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Health Technology |
Romark SCS
![]() Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg. | Health Technology |
- Stock Market
- Insiders
- Marc S. Ayers
- Experience